Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$15.96 - $22.18 $1.86 Million - $2.59 Million
-116,600 Reduced 34.53%
221,062 $3.78 Million
Q2 2023

Aug 11, 2023

SELL
$15.65 - $24.1 $1.36 Million - $2.1 Million
-87,193 Reduced 20.52%
337,662 $7.84 Million
Q4 2022

Feb 10, 2023

BUY
$17.09 - $27.91 $1.36 Million - $2.21 Million
79,356 Added 22.97%
424,855 $11.6 Million
Q3 2022

Nov 10, 2022

BUY
$15.6 - $21.15 $147,232 - $199,613
9,438 Added 2.81%
345,499 $5.97 Million
Q2 2022

Aug 11, 2022

BUY
$13.32 - $19.98 $1.01 Million - $1.51 Million
75,812 Added 29.13%
336,061 $5.87 Million
Q1 2022

May 16, 2022

BUY
$15.24 - $29.75 $2.56 Million - $5 Million
167,924 Added 181.88%
260,249 $4.42 Million
Q4 2021

Feb 14, 2022

SELL
$25.43 - $34.25 $935,824 - $1.26 Million
-36,800 Reduced 28.5%
92,325 $2.5 Million
Q3 2021

Nov 12, 2021

BUY
$28.98 - $39.54 $280,526 - $382,747
9,680 Added 8.1%
129,125 $3.83 Million
Q2 2021

Aug 13, 2021

BUY
$28.5 - $39.37 $1.3 Million - $1.8 Million
45,719 Added 62.01%
119,445 $4.59 Million
Q1 2021

May 17, 2021

BUY
$30.22 - $45.57 $393,011 - $592,637
13,005 Added 21.42%
73,726 $2.25 Million
Q4 2020

Feb 16, 2021

BUY
$23.5 - $52.65 $1.43 Million - $3.2 Million
60,721 New
60,721 $2.32 Million

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $631M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.